Nanjing Vazyme Biotech Co., Ltd

XSSC:688105 Stock Report

Market Cap: CN¥9.0b

Nanjing Vazyme Biotech Management

Management criteria checks 4/4

Nanjing Vazyme Biotech's CEO is Lin Cao, appointed in May 2020, has a tenure of 4.5 years. directly owns 7.38% of the company’s shares, worth CN¥665.48M. The average tenure of the management team and the board of directors is 4.5 years and 4.5 years respectively.

Key information

Lin Cao

Chief executive officer

CN¥729.9k

Total compensation

CEO salary percentagen/a
CEO tenure4.5yrs
CEO ownership7.4%
Management average tenure4.5yrs
Board average tenure4.5yrs

Recent management updates

Recent updates


CEO

Lin Cao (45 yo)

4.5yrs

Tenure

CN¥729,900

Compensation

Mr. Lin Cao is Chairman of the Board and General Manager of Nanjing Vazyme Biotech Co. Ltd from May 2020.


Leadership Team

NamePositionTenureCompensationOwnership
Lin Cao
Chairman of the Board & GM4.5yrsCN¥729.90k7.38%
CN¥ 665.5m
Lijun Zhang
Deputy GM & Director4.5yrsCN¥673.30kno data
Jin Huang
Board Secretary4.5yrsCN¥659.00kno data
Xiaoyu Xu
Deputy General Manager4.5yrsCN¥670.20kno data
Kai Shen
Accounting Supervisorno datano datano data

4.5yrs

Average Tenure

40.5yo

Average Age

Experienced Management: 688105's management team is considered experienced (4.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Lin Cao
Chairman of the Board & GM4.5yrsCN¥729.90k7.38%
CN¥ 665.5m
Lijun Zhang
Deputy GM & Director4.5yrsCN¥673.30kno data
Jiangnan Cai
Independent Director4.5yrsCN¥150.00kno data
Kuanyun Xia
Independent Director4.5yrsCN¥150.00kno data
Bo Tang
Director4.5yrsCN¥669.30kno data
Wei Dong
Independent Director4.2yrsCN¥150.00kno data

4.5yrs

Average Tenure

52.5yo

Average Age

Experienced Board: 688105's board of directors are considered experienced (4.5 years average tenure).